CRNX icon

Crinetics Pharmaceuticals

222 hedge funds and large institutions have $3.01B invested in Crinetics Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 96 increasing their positions, 64 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
222
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.14M
Puts
$428K
Net Calls
Net Calls Change

Top Buyers

1 +$35.1M
2 +$17.7M
3 +$13.8M
4
RI
RTW Investments
New York
+$13.4M
5
Goldman Sachs
Goldman Sachs
New York
+$11.5M
Name Holding Trade Value Shares
Change
Change in
Stake
PS
201
Principal Securities
Iowa
$2.3K
RAM
202
Riggs Asset Management
Pennsylvania
$1.7K
PFBT
203
Parkside Financial Bank & Trust
Missouri
$1.35K
PWMG
204
Private Wealth Management Group
New Jersey
$1.29K
LFG
205
Larson Financial Group
Missouri
$1.26K
BIG
206
Brooklyn Investment Group
New York
$1.06K
CIA
207
Cape Investment Advisory
Georgia
$892
WTC
208
WhitTier Trust Company
Nevada
$862
SO
209
Sierra Ocean
California
$834
Jones Financial Companies
210
Jones Financial Companies
Missouri
$809
WB
211
Webster Bank
Connecticut
$805
WSFS
212
Wilmington Savings Fund Society
Delaware
$575
PPC
213
Park Place Capital
Alabama
$512
BFS
214
Bare Financial Services
Pennsylvania
$460
TWD
215
True Wealth Design
Ohio
$374
CSS
216
Cubist Systematic Strategies
Connecticut
$374
BIA
217
Bell Investment Advisors
California
$288
TPWA
218
Twin Peaks Wealth Advisors
California
$171
CPG
219
Cornerstone Planning Group
New Jersey
$117
CIAM
220
Caitong International Asset Management
Hong Kong
$29
LGM
221
Logos Global Management
California
IHAM
222
Integral Health Asset Management
New York
CM
223
Caption Management
Oklahoma
Principal Financial Group
224
Principal Financial Group
Iowa
SVCM
225
Saturn V Capital Management
Texas